QuickView for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=9DABAE7CBAB5BEE957270089B238B32A;jsessionid=6287525E6B3D754F301BD4B10017F956;jsessionid=BA4170FCACA44D4A4FCD304608C198F8;jsessionid=AC9053CC5656DFB1D6E5AA449CC4A9B4;jsessionid=B8496FFCC7948F5C07EAD716852E4E3B (gene)

1. Thymic stroma and TFII-I: towards new targeted therapies.
2. Proteomic analysis of SRF associated transcription complexes identified TFII-I as modulator of SRF f…
3. Structural basis for evolutionarily conserved interactions between TFIIS and Paf1C.
4. The TFIIS N-terminal domain (TND): a transcription assembly module at the interface of order and dis…
5. Astragaloside IV attenuates sunitinib-associated cardiotoxicity by inhibiting COUP-TFII.

There were no clinical trials for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=9DABAE7CBAB5BEE957270089B238B32A;jsessionid=6287525E6B3D754F301BD4B10017F956;jsessionid=BA4170FCACA44D4A4FCD304608C198F8;jsessionid=AC9053CC5656DFB1D6E5AA449CC4A9B4;jsessionid=B8496FFCC7948F5C07EAD716852E4E3B